In this study, a combination of two ELISA tests based on VCA-IgA and EBNA1-IgA was applied to improve the effect of NPC screening by using a multiplication model and the NPC screening effect of the markers was evaluated. This evidence concerns the gene CD79A and nasopharyngeal carcinoma.